The Case For and Against
PSA-based Screening
Screening with prostate specific antigen (PSA) blood testing is used by more than 60% of men over age 50. Despite this, controversy swirls around its use for this purpose, stemming from disagreements on whether and by how much it truly benefits men with regard to prostate cancer, and because of the major consequences, both physically and economically, of diagnostic work-ups and treatment for those who are screened. Two huge randomized trials were conducted with the hope that their results would resolve the issue one way or the other, but their recent publication has done little to quell the concerns and opinions of those on either side. We present pro and con articles to outline key issues on each side of this debate.
The Case For PSA-based Screening
The Case Against PSA-based Screening

Dr. Margaret Foti: A Lifelong Commitment to Cancer Prevention
Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the American Association for Cancer Research, does not rest. She acts with an urgency that stems from leading a war against cancer that has not yet been won. [more]

A Safer, Effective Alternative to Surgery for Barrett's Esophagus
Radiofrequency ablation works well against this precursor condition to esophageal cancer. [more]

Spotlight On...
Over the past three decades, our scientific understanding of colorectal cancer has grown exponentially, shedding light onto a once obscure and highly lethal disease. Much of that illumination has come from a singular source: the tireless, innovative work of Dr. John D. Potter. [more]

New York City's Efforts Pay Off as Colonoscopy Screenings Rise
Within 5 years, uptake for those 50 and over climbs from 42% to 66% [more]